Castle Biosciences CSTL Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's common stock, shares authorized (in shares)?
- Castle Biosciences (CSTL) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
- How has Castle Biosciences's common stock, shares authorized (in shares) changed year-over-year?
- Castle Biosciences's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Castle Biosciences's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Castle Biosciences's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $200M to $200M.